| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cell and Tumor Biology |
Institute for Cell and Molecular Science, Queen Mary University of London, Whitechapel, London, United Kingdom
Requests for reprints: Ian C. Mackenzie, Institute for Cell and Molecular Science, Queen Mary University of London, 2 Newark Street, Whitechapel, London E1 2AT, United Kingdom. Phone: 0207-882-7159; Fax: 0207-882-7171; E-mail: i.c.mackenzie{at}qmul.ac.uk.
Recent work indicates that the growth and behavior of cancers are ultimately determined by a small subpopulation of malignant stem cells and that information about the properties of these cells is urgently needed to enable their targeting for therapeutic elimination. A key feature of normal stem cells is their asymmetrical division, the mechanism that allows stem cell self-renewal while producing hierarchies of amplifying and differentiating cells that form the bulk of the tissue. Most cancer deaths result from epithelial malignancies, but the extent to which the hierarchical proliferative stem and amplifying cell patterns of normal epithelia are actually retained in epithelial malignancies has been unclear. Here we show that even cell lines generated from carcinomas consistently produce in vitro colony patterns unexpectedly similar to those produced by the stem and amplifying cells of normal epithelia. From the differing types of colony morphologies formed, it is possible to predict both the growth potential of their constituent cells and their patterns of macromolecular expression. Maintenance of a subpopulation of stem cells during passage of cell lines indicates that the key stem cell property of asymmetrical division persists but is shifted towards enhanced stem cell self-renewal. The presence of malignant epithelial stem cells in vivo has been shown by serial transplantation of primary cancer cells and the present observations indicate that stem cell patterns are robust and persist even in cell lines. An understanding of this behavior should facilitate studies directed towards the molecular or pharmacologic manipulation of malignant stem cell survival.
This article has been cited by other articles:
![]() |
S. Nurmenniemi, T. Sinikumpu, I. Alahuhta, S. Salo, M. Sutinen, M. Santala, J. Risteli, P. Nyberg, and T. Salo A Novel Organotypic Model Mimics the Tumor Microenvironment Am. J. Pathol., September 1, 2009; 175(3): 1281 - 1291. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Trosko Review Paper: Cancer Stem Cells and Cancer Nonstem Cells: From Adult Stem Cells or from Reprogramming of Differentiated Somatic Cells Veterinary Pathology, March 1, 2009; 46(2): 176 - 193. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bhattacharya, J. Kwon, B. Ali, E. Wang, S. Patra, V. Shridhar, and P. Mukherjee Role of Hedgehog Signaling in Ovarian Cancer Clin. Cancer Res., December 1, 2008; 14(23): 7659 - 7666. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-H. Chiou, C.-C. Yu, C.-Y. Huang, S.-C. Lin, C.-J. Liu, T.-H. Tsai, S.-H. Chou, C.-S. Chien, H.-H. Ku, and J.-F. Lo Positive Correlations of Oct-4 and Nanog in Oral Cancer Stem-Like Cells and High-Grade Oral Squamous Cell Carcinoma Clin. Cancer Res., July 1, 2008; 14(13): 4085 - 4095. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Zhang, C. Balch, M. W. Chan, H.-C. Lai, D. Matei, J. M. Schilder, P. S. Yan, T. H-M. Huang, and K. P. Nephew Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human Tumors Cancer Res., June 1, 2008; 68(11): 4311 - 4320. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. B. Horwitz, W. W. Dye, J. C. Harrell, P. Kabos, and C. A. Sartorius Rare steroid receptor-negative basal-like tumorigenic cells in luminal subtype human breast cancer xenografts PNAS, April 15, 2008; 105(15): 5774 - 5779. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Engelmann, H. Shen, and O. J. Finn MCF7 Side Population Cells with Characteristics of Cancer Stem/Progenitor Cells Express the Tumor Antigen MUC1 Cancer Res., April 1, 2008; 68(7): 2419 - 2426. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Li, X. Chen, T. Calhoun-Davis, K. Claypool, and D. G. Tang PC3 Human Prostate Carcinoma Cell Holoclones Contain Self-renewing Tumor-Initiating Cells Cancer Res., March 15, 2008; 68(6): 1820 - 1825. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Tang, N. Yoo, M. Vu, M. Mamura, J.-S. Nam, A. Ooshima, Z. Du, P.-Y. Desprez, M. R. Anver, A. M. Michalowska, et al. Transforming Growth Factor-{beta} Can Suppress Tumorigenesis through Effects on the Putative Cancer Stem or Early Progenitor Cell and Committed Progeny in a Breast Cancer Xenograft Model Cancer Res., September 15, 2007; 67(18): 8643 - 8652. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Jin, S. Park, D. Z. Ewton, and E. Friedman The Survival Kinase Mirk/Dyrk1B Is a Downstream Effector of Oncogenic K-ras in Pancreatic Cancer Cancer Res., August 1, 2007; 67(15): 7247 - 7255. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Villadsen, A. J. Fridriksdottir, L. Ronnov-Jessen, T. Gudjonsson, F. Rank, M. A. LaBarge, M. J. Bissell, and O. W. Petersen Evidence for a stem cell hierarchy in the adult human breast J. Cell Biol., April 9, 2007; 177(1): 87 - 101. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |